logo
Select company
Select metric
-210.4%EBIT Margin
VS
Market
10
Sector
33
Industry
58
History
82
$ 41.6Close
$ 8.99 - $ 42.98 52-Week Range
Ticker Information

Ticker

TVRD

Company Name

TVARDI THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

TVARDI THERAPEUTICS INC - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TVRD - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
6/30/2025$ -13.84M-210.4%$ 6.58M
3/31/2025$ -36.12M-477.04%$ 7.57M
12/31/2024$ -62.79M-879.81%$ 7.14M
9/30/2024$ -89.07M-1025.43%$ 8.69M
6/30/2024$ -106.58M-969.31%$ 11M
3/31/2024$ -119.96M-708.22%$ 16.94M
12/31/2023$ -117.91M-562.33%$ 20.97M
9/30/2023$ -116.52M-548.95%$ 21.23M
6/30/2023$ -111.66M-410.95%$ 27.17M
3/31/2023$ -84.39M-195.16%$ 43.24M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • TVARDI THERAPEUTICS INC's latest trailing twelve months (TTM) EBIT % stands at -362.54%.
  • Over the past 5 years, TVARDI THERAPEUTICS INC's average EBIT % has been -380.86%.
  • The median EBIT % for TVARDI THERAPEUTICS INC during this period was -360.71%
  • TVARDI THERAPEUTICS INC reached its highest EBIT % over the past 5 years at 17.57%.
  • The lowest EBIT % recorded by TVARDI THERAPEUTICS INC in the same timeframe -1025.43%

TVARDI THERAPEUTICS INC's EBIT % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT % Benchmarks
CompanyEBIT %
CRBU : CARIBOU BIOSCIENCES INC -2427.19%KRRO : KORRO BIO INC -1452.95%OCGN : OCUGEN INC -1156.27%TCRX : TSCAN THERAPEUTICS INC -1920.2%LCTX : LINEAGE CELL THERAPEUTICS INC -374.84%ACOG : ALPHA COGNITION INC -434.42%OVID : OVID THERAPEUTICS INC -574.02%CRVO : CERVOMED INC -290.75%QSI : QUANTUM-SI INC -3117.58%FATE : FATE THERAPEUTICS INC -2025.05%

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for TVARDI THERAPEUTICS INC is calculated as follows: EBIT [ $ -99.71M ] / Revenues [ $ 27.5M ]
(=) EBIT % [ -362.54% ]

TVRD - EBIT Margin, Last 5 years

-1025.43%

Minimum

Sep 30, 2024

17.57%

Maximum

Sep 30, 2021

-380.86%

Average

-360.71%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.55% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-73.16%
max83.08%
average9.55%
median9.01%
std23.96%